Flex Pharma, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2014)
Status: Acquired by Salarius Pharmaceuticals, LLC (2019)

Organization Overview

First Clinical Trial
2017
NCT03196375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Mergers & Acquisitions

Historical Acquisition Tree